Why Does Ozempic® (semaglutide) Slow Down Your Stomach? Ever wonder why Ozempic can make you feel full sooner or for longer? One important part of the answer involves what happens inside your stomach. Ozempic contains semaglutide, a GLP-1 receptor agonist. Semaglutide can delay early post-meal gastric emptying, meaning food moves from the stomach into the small intestine more gradually. This can reduce the rate at which glucose appears in the bloodstream after a meal. But what does that actually mean for your body? In this Rehealthify Short, we break down: • What gastric emptying actually means • How semaglutide and GLP-1 work • Why Ozempic can slow the movement of food from the stomach • How this can affect blood sugar after eating • How GLP-1 signaling affects insulin and glucagon • Why you may experience fullness, nausea, vomiting, abdominal pain, or constipation while taking Ozempic And here's the important distinction: Ozempic doesn't simply “stop” your stomach. It can delay gastric emptying—one part of a much larger process involving the digestive system, pancreas, blood glucose, and brain. If you want to understand what Ozempic and other GLP-1 medications are actually doing inside your body, subscribe to Rehealthify for more clear, science-based health explainers. Subscribe and follow along as we break down the science behind the medications, conditions, and health questions people are searching for every day. IMPORTANT MEDICAL DISCLAIMER This video is provided for general educational and informational purposes only and is not medical advice, diagnosis, or treatment. Ozempic® (semaglutide) is a prescription medication. Do not start, stop, or change a medication or dosage based solely on information presented in this video. Always discuss your individual situation, medications, symptoms, and treatment options with a qualified healthcare professional. Medication effects can vary from person to person. Ozempic has important warnings, precautions, contraindications, and potential adverse reactions that are not fully covered in this Short. The current prescribing information lists, among other warnings, gastrointestinal adverse reactions and other serious risks. If you are experiencing severe or persistent symptoms while taking a medication, seek appropriate medical advice. BRAND DISCLAIMER Ozempic® is a registered trademark of Novo Nordisk A/S. Rehealthify is not affiliated with, sponsored by, or endorsed by Novo Nordisk. SOURCES & REFERENCES U.S. FDA — Ozempic (semaglutide) Prescribing Information The FDA-approved prescribing information describes semaglutide's effects on insulin and glucagon and states that semaglutide causes a delay in early postprandial gastric emptying. FDA Ozempic Prescribing Information DailyMed — Ozempic (semaglutide) Prescribing Information DailyMed's current labeling, revised May 2026, includes information about delayed gastric emptying, gastrointestinal adverse reactions, drug interactions, warnings, and precautions. DailyMed Ozempic Prescribing Information National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIDDK explains how GLP-1–based medications can affect gastric emptying, appetite, satiety, and blood glucose. NIDDK — GLP-1 Medications and Gastric Emptying SEARCH TERMS ozempic, ozempic semaglutide, semaglutide, ozempic stomach, ozempic gastric emptying, ozempic slows stomach, why does ozempic slow your stomach, how ozempic works, how semaglutide works, ozempic digestion, ozempic fullness, ozempic appetite, glp-1, glp-1 receptor agonist, gastric emptying, type 2 diabetes, blood sugar, insulin, glucagon, diabetes education, semaglutide side effects #ozempic #semaglutide #glp1 #type2diabetes #diabetes #bloodsugar #gastricemptying #insulin #health #medicaleducation #rehealthify